Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets
- 548 Downloads
Southern Africa is the region worst affected by HIV in the world and accounts for one third of the global burden of HIV. Achieving the UNAIDS 90-90-90 target by 2020 and ending the AIDS epidemic by 2030 depend on success in this region. We review epidemiological trends in each country in southern Africa with respect to the prevalence, incidence, mortality, coverage of anti-retroviral therapy (ART) and TB notification rates, to better understand progress in controlling HIV and TB and to determine what needs to be done to reach the UNAIDS targets. Significant progress has been made in controlling HIV. In all countries in the region, the prevalence of HIV in people not on ART, the incidence of HIV, AIDS-related mortality and, in most countries, TB notification rates, are falling. In some countries, the risk of infection began to fall before biomedical interventions such as ART became widely available as a result of effective prevention measures or people’s awareness of, and response to, the epidemic but the reasons for these declines remain uncertain. Some countries have achieved better levels of ART coverage than others, but all are in a position to reach the 2020 and 2030 targets if they accelerate the roll-out of ART and of targeted prevention efforts. Achieving the HIV treatment targets will further reduce the incidence of HIV-related TB, but efforts to control TB in HIV-negative people must be improved and strengthened.
KeywordsHIV TB Eastern and Southern Africa Ending AIDS UNAIDS targets ART
The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of UNAIDS.
Compliance with Ethics Guidelines
Conflict of Interest
Brian G. Williams, Eleanor Gouws, Pierre Somse, Mpho Mmelesi, Chibwe Lwamba, Trouble Chikoko, Erika Fazito, Mohamed Turay, Eva Kiwango, Pepukai Chikukwa, Henry Damisoni and Michael Gboun declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.UNAIDS. The Gap Report. Geneva: United Nations Joint Programme on HIV/AIDS. Available from: http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report (2014).
- 2.•UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. Geneva: United Nations Joint Programme on HIV/AIDS. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/JC2670_UNAIDS_Treatment_Targets_en.pdf (2014). This documents sets and defines the UNAIDS targets for 2020 and 2030.
- 3.Department of International Economic and Social Affairs. World demographic estimates and projections, 1950–2025 United Nations, New York 1988.Google Scholar
- 4.Williams BG. Responding to the AIDS epidemic in Angola. arXiv. Electronic version: http://arxiv.org/pdf/1401.6430v1 (2014).
- 5.Williams BG. Optimizing control of HIV in Kenya. arXiv. Electronic version: http://arxiv.org/abs/1407.7801 (2014).
- 6.Williams BG. Managing HIV/AIDS in Malawi. arXiv. Electronic version: http://arxiv.org/abs/1409.4628 (2014).
- 7.Williams BG. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: cautions, caveats and the importance of parsimony. arXiv. Electronic version: http://arxiv.org/pdf/1403.7104 (2014).
- 8.Williams BG. Fitting and projecting HIV epidemics: data, structure and parsimony. arXiv. Electronic version: http://arxiv.org/abs/1304.3720 (2014).
- 10.WHO. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1.
- 15.•Gregson S, Gonese E, Hallett TB, Taruberekera N, Hargrove JW, Lopman B, et al. HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol. 2010;39:1311–23. Attempt to explain the decline in the epidemic of HIV in Zimbabwe. CrossRefPubMedCentralPubMedGoogle Scholar
- 16.Robb M. RV217: The early capture HIV cohort study (ECHO). Prospective identification of HIV infection prior to acute viraemia among high-risk populations. Poster Abstract 404. Presented at the Keystone Symposium. Whistler, British Columbia, Canada (2011).Google Scholar
- 17.Robb M. Viral dynamics and immune response in acute infection and their impact on viral set-point. In: Plenary session 02: a new look at the transmission event AIDS 2012 vaccine; Boston, 9–12 September 2012.Google Scholar
- 19.Harington JS, McGlashan ND, Chelkowska EZ. A century of migrant labour in the gold mines of South Africa. J S Afr Inst Min Metall. 2004; 65–71.Google Scholar
- 20.Brink B, Clausen L. The acquired immune deficiency syndrome. J Mine Med Off Assoc. 1987;63:10–7.Google Scholar
- 21.James WG. Our precious metal: African labour in South Africa’s gold industry, 1970–1990. Cape Town: David Philip; 1992.Google Scholar
- 22.Crush J, Jeeves A, Yudelman D. South Africa’s labour empire: a history of black migrancy to the gold mines. Boulder: Westview Press; 1991.Google Scholar
- 23.Maja, B. Towards a fairer deal for migrants in the South African Economy, Labour Market Review, Department of Labour, Republic of South Africa; 2007Google Scholar
- 24.Demographics of Swaziland. Available from: http://en.wikipedia.org/wiki/Demographics_of_Swaziland#Population_2.
- 25.Williams BG, MacPhail C, Campbell C, Taljaard D, Gouws E, Moema S, et al. The Carletonville-Mothusimpilo project: limiting transmission of HIV through community-based interventions. S Afr J Sci. 2000;96:351–9.Google Scholar
- 29.Williams BG, Gouws E, Lurie M, Crush J. Spaces of vulnerability: migration and HIV/AIDS in South Africa. 2002; Southern African migration project: migration policy series No 24. Cape Town: Queens University; 2002. Available from: Southern Africa Migration Project http://www.queensu.ca/samp/sampresources/samppublications/policyseries/Acrobat24.pdf
- 32.Cohen B, Trussell J (Editors) Preventing and mitigating AIDS in Sub-Saharan Africa: research and data priorities for the social and behavioral sciences (Washington, DC) (1996).Google Scholar
- 36.WHO. A brief history of tuberculosis control in Kenya. Geneva: World Health Organization; 2009. Available from: http://whqlibdoc.who.int/publications/2009/9789241596923_eng.pdf.
- 38.Anonymous. National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2012. Department of Health, South Africa. Available from: www.doh.gov.za (2012).
- 41.•Malawi Department of Health. Integrated HIV Program Report: October – December. Blantyre: Ministry of Health, Malawi. Available from: http://www.hivunitmohmw.org/uploads/Main/Quarterly_HIV_Programme_Report_2012_Q4.pdf (2012). Patient monitoring in Malawi.
- 42.UNAIDS. Regional consultation to set new targets for the HIV response post-2015 in Eastern and Southern Africa. Johannesburg; 19–20 May 2014. Available from: www.unaidsrstesa.org (2014).
- 44.The Ministry of Health and Ministry of Community Development MaCH. Zambia consolidated guidelines for treatment and prevention of HIV infection. Lusaka. Available from: https://xa.yimg.com/…/Zambia+HIV+Consolidated+Guidelines+−+Feb+2014+Version+−final+draft-3 (2014).
- 45.Ministerio da Saude SNdS. Relatório Semestral das Actividades Relacionadas ao HIV/SIDA. Moçambique. 2014. Maputo.Google Scholar
- 46.Maman D. Chiradzulu HIV impact population survey. Ministry of Health of Malawi, Médecin Sans Frontières; 2013. Available from: http://www.epicentre.msf.org.
- 48.Gras L, Kesselring AM, Griffin JT, van Sighem AI, Fraser C, Ghani AC, et al. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr Hum Retrovirol. 2007;45:183–92.CrossRefGoogle Scholar
- 49.Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, et al. Impact of the data collection on adverse events of anti-HIV drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada. J Int Assoc Provid AIDS Care. 2014;13:153–9.CrossRefPubMedGoogle Scholar
- 51.UNAIDS. Fast-track: ending the AIDS epidemic by 2030. Geneva: United Nations Joint Programme on HIV/AIDS; 2014. Available from: http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf.
- 52.PEPFAR 3.0: Controlling the epidemic: delivering on the promise of an AIDS-free Generation. Available at http://www.pepfar.gov/documents/organization/234744.pdf.